FDG-PET/CT of Giant Cell Arteritis with Normal Inflammatory Markers
Ann Neurol 92:337-339, Koizumi, N.,et al, 2022
Single Photon Emission Computed Tomography/Positron Emission Tomography Molecular Imaging for Parkinsonism: A Fast-Developing Field
Ann Neurol 90:711-719, Verger, A.,et al, 2021
Determination of Brain Death
NEJM 385:2554-2561, Greer, D.M., 2021
EULAR Recommendations for the Use of Imaging in Large Vessel Vasculitis in Clinical Practice
Ann Rheum Dis 77:636-643, Dejaco,C.,et al, 2018
Autopsy Validation of ���I-FP-CIT Dopaminergic Neuroimaging for the Diagnosis of DLB
Neurol 88:276-283, Thomas, A.J.,et al, 2017
Prevalence of Amyloid PET Positivity in Dementia Syndromes
JAMA 313:1939-1949,1913, Ossenkoppele, R.,et al, 2015
Non-Alzheimers Dementia 1 Frontotemporal Dementia
Lancet 386:1672-1682, Bang, Jee.,et al, 2015
Non-Alzheimers Dementia 2 Lewy Body Dementias
Lancet 386:1683-1697, Walker, Z.,et al, 2015
PET Imaging for Alzheimer Disease: Are Its Benefits Worth the Cost?
JAMA 309:1099-1100, Mitka, M., 2013
Brain Amyloid Imaging - FDA Approval of Florbetapir F18 Injection
NEJM 367:885-887, Yang, L.,et al, 2012
Role of Brain Imaging in Early Parkinsonism
BMJ 324:d638, Breen,D.P.,et al, 2011
Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011
Changing Concepts of Alzheimer Disease
JAMA 35:2458-2459, McKhann, G.M., 2011
Mild Cognitive Impairment
NEJM 362:2227-2234, Peterson, R.C., 2011
FDG-PET a Pivotal Imaging Modality for Diagnosis of Stroke-Onset Intravascular Lymphoma
Arch Neurol 67:366-367, Yamada,S.,et al, 2010
The Case Against Confirmatory Tests for Determining Brain Death in Adults
Neurol 75:77-83, Wijdicks,E.F.M., 2010
AIDS - Related Lymphomas: Primary CNS Lymphoma
UpToDate, April, Doweiko, J.P., 2010
Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimers Disease
AJNR 31:347-354, Walhovd, K.B.,et al, 2010
Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009
Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia
Arch Neurol 63:144-146,146, Rikkert,M.G.M.O.,et al, 2006
Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
Early Clinical Signs and Imaging Findings in Gerstmann-Straussler-Scheinker Syndrome (Pro102Leu)
Neurol 66:1672-1678, Arata,H.,et al, 2006
Diagnosis of Neurolymphomatosis with FDG PET
Neurol 67:722-723, Rosso,S.M.,et al, 2006
PET of Brain Amyloid and Tau in Mild Cognitive Impairment
NEJM 355:2652-2663, Small,G.W.,et al, 2006
Detection of Unknown Primary Tumor in a Patient with Cerebellar Metastasis Using FDG PET-CT: Case Report
No Shinkei Geka 34:1027-1032, Ishiguro,T.,et al, 2006
Whole-Body MRI and PET-CT in the Management of Cancer Patients
Eur Radiol 16:1216-1225, Schmidt,G.P.,et al, 2006
Lesion Size Determines Accuracy of Thallium-201 Brain Single-Photon Emission Tomography in Differentiating Between Intracranial Malignancy and Infection in AIDS Patients
AJNR 26:1973-1979, Younhg,R.J.,et al, 2005
Clinical Features and Diagnosis of Primary Central Nervous System Lymphoma
Hematol Oncol Clin North Am 19:689-703, Fitzsimmons,A.,et al, 2005
Unknown Primary Tumors: Detection with Dual-Modality PET/CT--Initial Experience
Radiology 234:227-234, Gutzeit,A.,et al, 2005
Idiopathic Hyposmia As a Preclinical Sign of Parkinson's Disease
Ann Neurol 56:173-181,169, Ponsen,M.M.,et al, 2004
Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003
Primary Progressive Aphasia--A Language-Based Dementia
NEJM 349:1535-1542, Mesulam,M.-M., 2003
Positron Emission Tomography in Evaluation of Dementia
JAMA 286:2120-2127,2194, Silverman,D.H.S.,et al, 2001
Value of Combined Approach with Thallium-201 Single-Proton Emission Computed Tomography and Epstein-Barr Virus DNA Polymerase Chain Reaction in CSF for the Diagnosis of AIDS-Related Primary CNS Lympho
J Clin Oncol 17:554-560, Antinori,A.,et al, 1999
Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999
A Clinical Role for 99mTC-HMPAO SPECT in the Investigation of Dementia
JNNP 64:306-313, Talbot,P.R.,et al, 1998
SPECT in the Identif of New Variant Creutzfeldt-Jakob Disease:Case Reports
BMJ 316:593-594, 5631998., deSilva,R.,et al, 1998
The Role of 99m-Tc HMPAO SPECT in the Diagnosis of Creutzfeldt-Jacob Disease
AJNR 19:454-455, Miller,D.A.,et al, 1998
Evaluation and Management of Intracranial Mass Lesions in AIDS
Rpt of Quality Stnds Subcomm of the AAN, Neurol 50:21-261998., , 1998
Preclinical Prediction of Alzheimer's Disease Using SPECT
Neurol 50:1563-1571, Johnson,K.A.,et al, 1998
Cerebral Toxoplasmosis and Lymphoma in AIDS: Perfusion MR Imaging Experience in 13 Patients
Radiology 208:663-669, Ernst,T.M.,et al, 1998
Sympathetic Cardioneuropathy in Dysautonomias
NEJM 336:696-702, 7211997., Goldstein,D.S.,et al, 1997
Diffusion-Weighted Magnetic Resonance Imaging in Creutzfeldt-Jakob Disease
Lancet 349:847-848, Demarerel,P.,et al, 1997
Practice Guidelines for the Use of Imaging in Transient Ischemic Attacks and Acute Stroke
Stroke 28:1480-1497, Culebras,A.,et al, 1997
Brain Death:MR and MR Angiography
AJNR 17:731-735, Ishii,K.,et al, 1996
Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the e4Allele for Apolipoprotein E
NEJM 334:752-758, 7911996., Reiman,E.M.,et al, 1996
Management Protocol for an Enhancing Cerebral Lesion in HIV Infection
Conn Medicine 60:649-651, Finelli,P.F., 1996
Evaluating Contrast-Enhancing Brain Lesions in Patients with AIDS by Using Positron Emission Tomography
Ann Int Med 123:594-598, Pierce,M.A.,et al, 1995
Early Differential Diagnosis of Parkinson's Disease with F-flurodeoxyglucose and Positron Emission Tomography
Neurol 45:1995-2004, Eidelberg,D.,et al, 1995